View Archive

Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Boehringer Ingelheim and Eli Lilly.

Utilizing Real-World Evidence to Optimize Outcomes in Type 2 Diabetes – Reducing Cardiovascular Disease & CV Risk

Utilizing Real-World Evidence to Optimize Outcomes in Type 2 Diabetes – Reducing Cardiovascular Disease & CV Risk

Friday, July 23, 2021
7:30 pm - 9:30 pm CDT


The interrelationship between type 2 diabetes (T2D) and cardiovascular disease (CVD) contributes significantly to diabetes-related disease burden and cost but CVD risk reduction cannot be achieved simply by attaining A1C goals. Although findings from the cardiovascular outcomes trials have resulted in significant changes to the treatment paradigm for diabetes, real-world data can further support individualized treatment for patients with T2D. Moreover, optimizing the care of patients with T2D to avoid hospitalization due to CV events or heart failure exacerbations has become even more imperative during the coronavirus disease 2019 (COVID-19) pandemic.

During this live satellite symposium, expert faculty will review current guidelines for the treatment of patients with T2D and CVD while sharing their approaches regarding the selection of antihyperglycemic agents. They will present real-world evidence on the efficacy and safety of newer agents to encourage practice-changing behavior with a view to reducing diabetes complications and CVD risk in patients with T2D.

Physicians’ Education Resource®’s top priority is ensuring the safety and security of our attendees, faculty, exhibitors, staff, and operational personnel. We are dedicated to remaining informed about the ongoing COVID-19 pandemic at global and local levels. As we develop the programming for this activity, PER is working diligently to implement health and safety protocols based on the advice of health experts and the latest guidelines and local regulations to mitigate the risk of exposure to COVID-19 and to optimize health and safety conditions for attendees during the event. Ongoing updates to Physicians’ Education Resource®’s plans related to this event, including education and programming, will be available at https://www.gotoper.com/conferences/aspc21t2d/meetings/t2d21cvd. Please note: attendance at any public event increases the risk of contracting COVID-19 or other airborne illnesses, and attendees assume all risk associated with attendance. Any attendees who feel ill, regardless of their symptoms, should not attend this event.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Boehringer Ingelheim and Eli Lilly.

Benefits of Attending

  • Get up to date on current recommendations and guidelines for patients with T2D and CVD
  • Gain insight into practical treatment approaches to reduce complications and CVD risk for patients with T2D
  • Hear expert perspectives on how to integrate real-world evidence into current treatment paradigms for T2D
  • Network with leading faculty through live Q&A sessions

Target Audience

This educational program is directed toward all attendees of the 2021 ASCP Internal Medicine Meeting. We invite primary care physicians, diabetologists, endocrinologists, cardiologists, certified diabetes educators, nurse practitioners, physicians’ assistants, and other health care providers who treat patients with T2D to participate in the online enduring program.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Review current treatment guidelines for the reduction of CVD risk in patients with T2D
  • Evaluate the real-world evidence for reducing CV events and hospitalization to improve outcomes for patients with T2D
  • Apply emerging clinical data on issues concerning the treatment and prevention of CVD in patients with T2D


3 Ways to Register

  1. Online: Click here.
  2. Phone: Please call +1-(888)-949-0045 or +1-(609)-378-3701 (credit cards only).
  3. Fax: +1-(609)-257-0705 (credit cards only).

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image").  By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as part of the Affordable Care Act. Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the Act.

Calendar of Events
Filter By